Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)
Abstract Cancer survivors receiving doxorubicin may experience left ventricular ejection fraction (LVEF) decline during and following treatment; however, explanations for variations in decline beyond dosage differences, such as those related to socioeconomic status (SES), have not been fully examine...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | Cardio-Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40959-025-00311-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823861591446126592 |
|---|---|
| author | Arnethea L. Sutton Nathaniel S. O’Connell Alexander R. Lucas Kristine C. Olson Kerryn W. Reding Vanessa B. Sheppard Bonnie Ky Kathryn J. Ruddy Kathryn E. Weaver W. Gregory Hundley |
| author_facet | Arnethea L. Sutton Nathaniel S. O’Connell Alexander R. Lucas Kristine C. Olson Kerryn W. Reding Vanessa B. Sheppard Bonnie Ky Kathryn J. Ruddy Kathryn E. Weaver W. Gregory Hundley |
| author_sort | Arnethea L. Sutton |
| collection | DOAJ |
| description | Abstract Cancer survivors receiving doxorubicin may experience left ventricular ejection fraction (LVEF) decline during and following treatment; however, explanations for variations in decline beyond dosage differences, such as those related to socioeconomic status (SES), have not been fully examined. We conducted a retrospective analysis of a cohort of 215 breast cancer survivors receiving doxorubicin. SES factors (e.g., household income, education) were collected via a survey at a baseline and EF was assessed using magnetic resonance imaging. Linear regression models showed that prior to treatment, no SES factors were associated with LVEF. However, six months following treatment, survivors who were unemployed for reasons other than retirement and disability experienced greater LVEF declines compared to survivors who were employed ((b = 2.79 [95% confidence interval (CI): 0.37–5.20; p = 0.026). Our study demonstrated that non-clinical factors associated with social drivers of health, such as socioeconomic status, contribute to subclinical cardiovascular dysfunction and therefore supports further investigation of mechanisms behind these associations. Trial registration NCT01988571 (WF-98213). |
| format | Article |
| id | doaj-art-c8cf11e97e7c459695fae3e884bcbafd |
| institution | Kabale University |
| issn | 2057-3804 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | BMC |
| record_format | Article |
| series | Cardio-Oncology |
| spelling | doaj-art-c8cf11e97e7c459695fae3e884bcbafd2025-02-09T12:56:36ZengBMCCardio-Oncology2057-38042025-02-011111310.1186/s40959-025-00311-ySocioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)Arnethea L. Sutton0Nathaniel S. O’Connell1Alexander R. Lucas2Kristine C. Olson3Kerryn W. Reding4Vanessa B. Sheppard5Bonnie Ky6Kathryn J. Ruddy7Kathryn E. Weaver8W. Gregory Hundley9Virginia Commonwealth University College of Humanities and SciencesWake Forest University School of MedicineVirginia Commonwealth University School of Public HealthVirginia Commonwealth University School of MedicineUniversity of Washington School of NursingVirginia Commonwealth University School of Public HealthUniversity of PennsylvaniaMayo ClinicWake Forest University School of MedicineWake Forest University School of MedicineAbstract Cancer survivors receiving doxorubicin may experience left ventricular ejection fraction (LVEF) decline during and following treatment; however, explanations for variations in decline beyond dosage differences, such as those related to socioeconomic status (SES), have not been fully examined. We conducted a retrospective analysis of a cohort of 215 breast cancer survivors receiving doxorubicin. SES factors (e.g., household income, education) were collected via a survey at a baseline and EF was assessed using magnetic resonance imaging. Linear regression models showed that prior to treatment, no SES factors were associated with LVEF. However, six months following treatment, survivors who were unemployed for reasons other than retirement and disability experienced greater LVEF declines compared to survivors who were employed ((b = 2.79 [95% confidence interval (CI): 0.37–5.20; p = 0.026). Our study demonstrated that non-clinical factors associated with social drivers of health, such as socioeconomic status, contribute to subclinical cardiovascular dysfunction and therefore supports further investigation of mechanisms behind these associations. Trial registration NCT01988571 (WF-98213).https://doi.org/10.1186/s40959-025-00311-yBreast cancerLeft ventricular ejection fractionSocioeconomic statusSocial drivers of health |
| spellingShingle | Arnethea L. Sutton Nathaniel S. O’Connell Alexander R. Lucas Kristine C. Olson Kerryn W. Reding Vanessa B. Sheppard Bonnie Ky Kathryn J. Ruddy Kathryn E. Weaver W. Gregory Hundley Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213) Cardio-Oncology Breast cancer Left ventricular ejection fraction Socioeconomic status Social drivers of health |
| title | Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213) |
| title_full | Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213) |
| title_fullStr | Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213) |
| title_full_unstemmed | Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213) |
| title_short | Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213) |
| title_sort | socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin prevent wf 98213 |
| topic | Breast cancer Left ventricular ejection fraction Socioeconomic status Social drivers of health |
| url | https://doi.org/10.1186/s40959-025-00311-y |
| work_keys_str_mv | AT arnethealsutton socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT nathanielsoconnell socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT alexanderrlucas socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT kristinecolson socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT kerrynwreding socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT vanessabsheppard socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT bonnieky socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT kathrynjruddy socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT kathryneweaver socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 AT wgregoryhundley socioeconomicstatusandleftventricularejectionfractiondeclineinbreastcancersurvivorsfollowingreceiptofdoxorubicinpreventwf98213 |